BSE filing, NSE: DHARTI. Summary written from the filing by ALFA Finder's alert engine.
Dharti Proteins Ltd: key numbers
- Share price
- ₹108.94
- Market cap
- ₹5.45 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.85 Cr
- Promoter holding
- 85.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dharti Proteins Ltd
All →Dharti Proteins Bonus Issue
Dharti Proteins Limited issued an EOGM notice scheduled for November 06, 2026, to seek shareholder approval for a 1:1 bonus issue.
Dharti Proteins Financial Results
Dharti Proteins Ltd approved its audited standalone financial results for the quarter ended September 30, 2026, and recommended a 1:1 bonus issue of equity shares.
Dharti Proteins Bonus Issue
Dharti Proteins Limited approved a 1:1 bonus issue, capitalizing Rs.0.075 Crore from reserves. The record date is fixed for November 13, 2026.
- Value
- ₹0.07 Cr
Dharti Proteins Q2 FY27 Results: Net Profit ₹3.4 Cr
Dharti Proteins Ltd reported revenue from operations of ₹2.9 Cr and net profit of ₹3.4 Cr for Q2 FY27.
- Key figure
- Net profit ₹3.4 Cr
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.